Lipsitz O

Poul Hansen Family Centre for Depression, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada; Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada. Electronic address: orly.lipsitz@uhn.ca.

7 papers · ORCID

ArticlePsilocybin

Psychedelics as a potential treatment for borderline personality disorder: A narrative review.

Artna E, Sandhu G, Chisamore N +5

Europe PMC2026
ArticlePsilocybin

Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.

Johnson DE, Meshkat S, Kaczmarek ES +11

Europe PMC2025
ArticlePsilocybin

Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.

Brudner RM, Kaczmarek E, Blainey MG +9

Europe PMC2025
ArticlePsilocybin

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F +14

Europe PMC2022
ArticlePsilocybin

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Ling S, Ceban F, Lui LMW +12

Europe PMC2022
ArticlePsilocybin

Registered clinical studies investigating psychedelic drugs for psychiatric disorders.

Siegel AN, Meshkat S, Benitah K +6

Europe PMC2021
ArticlePsilocybin

The emerging role of psilocybin and MDMA in the treatment of mental illness.

Gill H, Gill B, Chen-Li D +11

Europe PMC2020